NCT07725042

Brief Summary

The goal of the project is to determine the epidemiologic status and changing patterns of HIV infection in Hong Kong. The main question it aims to answer is: \- what is the molecular pattern and burden of HIV-1 infections over the years

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
720

participants targeted

Target at P75+ for all trials

Timeline
38mo left

Started Aug 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Aug 2024Oct 2029

Study Start

First participant enrolled

August 1, 2024

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2029

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2029

Last Updated

July 24, 2026

Status Verified

July 1, 2026

Enrollment Period

4.9 years

First QC Date

July 21, 2026

Last Update Submit

July 21, 2026

Conditions

Keywords

HIVpeople living with HIVmolecular analysescommunity burdenepidemiologyHong Kong

Outcome Measures

Primary Outcomes (2)

  • main molecular HIV-1 subtype

    Proportion of patients infection with HIV-1 subtype B

    from enrollment to the end of the study at 4 years

  • main HIV transmission mode

    Proportion of patients who are men who have sex with men

    from enrollment to end of study at 4 years

Secondary Outcomes (2)

  • changes in HIV molecular pattern

    from enrolment to end of study at 4 years

  • Change in transmission mode

    from enrolment to end of study at 4 years

Study Arms (1)

people with newly diagnosed HIV infection

adults newly diagnosed with HIV infection who are of age 18 or above and attending the service of HIV specialist clinics in Hong Kong

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult people living with HIV attending a public clinical service in Hong Kong where HIV diagnosis has recently been made

You may qualify if:

  • adult of age 18 or above, who are
  • people living with HIV, and
  • attending the service of an HIV specialist clinic in the public service in Hong Kong

You may not qualify if:

  • travelers or visitors who are temporarily staying in Hong Kong
  • prisoners
  • patients with mental illnesses who are unable to make informed decision
  • patients whose HIV diagnosis was made outside Hong Kong and whose treatment have already started.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

S.H. Ho Research Centre for Infectious Diseases

North Point, 0000, Hong Kong

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples for RNA extraction and sequencing

Study Officials

  • Shui Shan S Lee, MD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shui Shan Lee, MD

CONTACT

Ngai Sze Wong, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 24, 2026

Study Start

August 1, 2024

Primary Completion (Estimated)

July 1, 2029

Study Completion (Estimated)

October 1, 2029

Last Updated

July 24, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

IPD restricted to investigators as stipulated in the institutional approval

Locations